Recombinant vaccine against Japanese encephalitis virus (JEV) infection and a method thereof

Details for Australian Patent Application No. 2004312444 (hide)

Owner National Institute of Immunology

Inventors Vrati, Sudhanshu

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004312444

PCT Pub. Number WO2005/065707

Priority 1516/DEL/2003 04.01.04 IN

Filing date 30 December 2004

Wipo publication date 21 July 2005

Acceptance publication date 12 August 2010

International Classifications

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/065707 Priority application(s): WO2005/065707

12 August 2010 Application Accepted

  Published as AU-B-2004312444

9 December 2010 Standard Patent Sealed

26 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004312445-Pharmaceutical compositions comprising an extract of Euphorbia prostrata

2004312436-Particulate core preforming process